Giant Biogene Holding Co. Ltd. (HK:2367)
:2367
Want to see HK:2367 full AI Analyst Report?
2367 Stock Chart & Stats
HK$28.76
HK$0.10(0.22%)
At close: 4:00 PM EST
HK$28.76
HK$0.10(0.22%)
Day’s Range― - ―
52-Week RangeHK$26.40 - HK$65.70
Previous CloseN/A
Volume2.50M
Average Volume (3M)12.22M
Market Cap
HK$28.68B
Enterprise ValueHK$21.27B
Total Cash (Recent Filing)HK$8.29B
Total Debt (Recent Filing)HK$9.69M
Price to Earnings (P/E)13.2
Beta1.32
Next Earnings
Sep 01, 2026EPS Estimate
1.2Next Dividend Ex-DateN/A
Dividend Yield1.84%
Share Statistics
EPS (TTM)1.83
Shares Outstanding1,061,704,000
10 Day Avg. Volume16,417,830
30 Day Avg. Volume12,220,358
Financial Highlights & Ratios
PEG Ratio-1.28
Price to Book (P/B)3.19
Price to Sales (P/S)5.73
P/FCF Ratio21.35
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$40.06Price Target Upside39.28% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)1.83
Revenue Forecast (FY)HK$6.07B
Bulls Say, Bears Say
Bulls Say
Future Sales PotentialExpecting influencer live-streaming recovery, which should further boost online sales.
Revenue GrowthResilient revenue growth driven by multiple channels and dual brands.
Sales PerformanceSales growth on JD accelerated significantly, as evidenced by a 134% YoY increase in direct-to-platform e-commerce sales.
Bears Say
Channel PerformanceOffline channel contraction continues to drag Collgene’s overall growth.
Product ApprovalDespite approval delays for certain injectable products, Giant Biogene is well-positioned for long-term growth in the medical aesthetics market.
Profit MarginThe increase in revenue proportion of skincare products led to a decline in GPM from 83.6% to 82.1%.
Giant Biogene Holding Co. Ltd. News
2367 FAQ
What was Giant Biogene Holding Co. Ltd.’s price range in the past 12 months?
Giant Biogene Holding Co. Ltd. lowest stock price was HK$26.40 and its highest was HK$65.70 in the past 12 months.
What is Giant Biogene Holding Co. Ltd.’s market cap?
Giant Biogene Holding Co. Ltd.’s market cap is HK$28.68B.
When is Giant Biogene Holding Co. Ltd.’s upcoming earnings report date?
Giant Biogene Holding Co. Ltd.’s upcoming earnings report date is Sep 01, 2026 which is in 83 days.
How were Giant Biogene Holding Co. Ltd.’s earnings last quarter?
Giant Biogene Holding Co. Ltd. released its earnings results on Mar 19, 2026. The company reported HK$0.78 earnings per share for the quarter, missing the consensus estimate of HK$0.792 by -HK$0.011.
Is Giant Biogene Holding Co. Ltd. overvalued?
According to Wall Street analysts Giant Biogene Holding Co. Ltd.’s price is currently Undervalued.
Does Giant Biogene Holding Co. Ltd. pay dividends?
Giant Biogene Holding Co. Ltd. pays a Notavailable dividend of HK$1.389 which represents an annual dividend yield of 1.84%. See more information on Giant Biogene Holding Co. Ltd. dividends here
What is Giant Biogene Holding Co. Ltd.’s EPS estimate?
Giant Biogene Holding Co. Ltd.’s EPS estimate is 1.2.
How many shares outstanding does Giant Biogene Holding Co. Ltd. have?
Giant Biogene Holding Co. Ltd. has 1,061,704,000 shares outstanding.
What happened to Giant Biogene Holding Co. Ltd.’s price movement after its last earnings report?
Giant Biogene Holding Co. Ltd. reported an EPS of HK$0.78 in its last earnings report, missing expectations of HK$0.792. Following the earnings report the stock price went down -4.578%.
Which hedge fund is a major shareholder of Giant Biogene Holding Co. Ltd.?
Currently, no hedge funds are holding shares in HK:2367
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Giant Biogene Holding Co. Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-17.25%
12-Months-Change
Fundamentals
Return on Equity
20.06%
Trailing 12-Months
Asset Growth
41.16%
Trailing 12-Months
Company Description
Giant Biogene Holding Co. Ltd.
Giant Biogene Holding Co., Ltd. operates as an investment holding entity, primarily engaged in the research, development, production, and sale of beauty and wellness products based on bioactive materials throughout the People's Republic of China. The company also manufactures functional foods leveraging rare ginsenosides technology and provides medical devices. Its diverse product range, which includes specialized skincare, medical dressings, and nutritional supplements, is marketed predominantly under brand names such as Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan. Established in 2000, Giant Biogene Holding Co., Ltd. maintains its headquarters in Xi'an, PRC.
2367 Stock 12 Month Forecast
Average Price Target
HK$40.06
▲(39.28% Upside)
Technical Analysis
Hengan International Group Co
―
Ming Fai International Holdings
―
Natural Beauty Bio-Technology
―
Shanghai Chicmax Cosmetics Co., Ltd. Class H
―
Blue Moon Group Holdings Ltd.
―
Options Prices
Currently, No data available
---